Drug Search Results
More Filters [+]

Octenidine

Alternative Names: octenidine
Latest Update: 2024-08-16
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Gram+ Bacteria Inhibitor,Gram- Bacteria Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical,Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Austria | Bosnia | Bulgaria | Cyprus | Czech | Estonia | Germany | Greece | Hungary | India | Italy | Korea | Latvia | Lithuania | Luxembourg | Malta | New Zealand | Poland | Portugal | Romania | Russia | Serbia | Slovakia | Slovenia | Sweden | Switzerland | Turkey | Ukraine | United Arab Emirates

Approved Indications: None

Known Adverse Events: None

Company: Schülke & Mayr
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Octenidine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Catheter-Related Infections|Communicable Diseases|Bacteremia

Phase 3: Sepsis|Pharyngitis|Gingivitis

Phase 2: Healthy Volunteers|Gingivitis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT06522438

N/A

Not yet recruiting

Periodontal Pocket|Periodontitis|Periodontal Attachment Loss|Inflammation

2025-10-01

2006-7041-83/hah

N/A

Not yet recruiting

Stroke

2020-06-30

2017-001697-42

P3

Completed

Unknown

2018-12-14

OML-III-A

P3

Completed

Gingivitis

2018-12-14

55%

Recent News Events